CZ52297A3 - Pharmaceutical preparation for inhibiting primary endometrial hyperplasia - Google Patents

Pharmaceutical preparation for inhibiting primary endometrial hyperplasia Download PDF

Info

Publication number
CZ52297A3
CZ52297A3 CZ97522A CZ52297A CZ52297A3 CZ 52297 A3 CZ52297 A3 CZ 52297A3 CZ 97522 A CZ97522 A CZ 97522A CZ 52297 A CZ52297 A CZ 52297A CZ 52297 A3 CZ52297 A3 CZ 52297A3
Authority
CZ
Czechia
Prior art keywords
formula
endometrial hyperplasia
endometrial
estrogen
compound
Prior art date
Application number
CZ97522A
Other languages
Czech (cs)
English (en)
Inventor
Robin Sharon Lee Fuchs-Young
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CZ52297A3 publication Critical patent/CZ52297A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
CZ97522A 1994-08-22 1995-08-21 Pharmaceutical preparation for inhibiting primary endometrial hyperplasia CZ52297A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29412194A 1994-08-22 1994-08-22
PCT/US1995/010619 WO1996005832A1 (en) 1994-08-22 1995-08-21 Methods of inhibiting primary endometrial hyperplasia

Publications (1)

Publication Number Publication Date
CZ52297A3 true CZ52297A3 (en) 1997-08-13

Family

ID=23131973

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ97522A CZ52297A3 (en) 1994-08-22 1995-08-21 Pharmaceutical preparation for inhibiting primary endometrial hyperplasia

Country Status (20)

Country Link
EP (1) EP0771201B1 (de)
JP (1) JPH10504579A (de)
KR (1) KR970705388A (de)
AT (1) ATE200623T1 (de)
AU (1) AU706953B2 (de)
CA (1) CA2198120A1 (de)
CZ (1) CZ52297A3 (de)
DE (1) DE69520741T2 (de)
DK (1) DK0771201T3 (de)
ES (1) ES2155895T3 (de)
FI (1) FI970716A7 (de)
GR (1) GR3036225T3 (de)
HU (1) HUT76854A (de)
IL (1) IL115018A0 (de)
MX (1) MX9701359A (de)
MY (1) MY131931A (de)
NO (1) NO970787D0 (de)
PT (1) PT771201E (de)
WO (1) WO1996005832A1 (de)
ZA (1) ZA956988B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW404834B (en) * 1994-08-22 2000-09-11 Lilly Co Eli Pharmaceutical compositions for inhibiting endometrial cancer
US5843964A (en) * 1994-09-22 1998-12-01 Eli Lilly And Company Methods of inhibiting endometrial mitoses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
ZA948025B (en) * 1993-10-15 1996-04-15 Lilly Co Eli Methods for treating resistant neoplasms
US5461065A (en) * 1993-10-15 1995-10-24 Eli Lilly And Company Methods for inhibiting endometriosis

Also Published As

Publication number Publication date
EP0771201A4 (de) 1997-09-10
EP0771201A1 (de) 1997-05-07
MX9701359A (es) 1997-05-31
WO1996005832A1 (en) 1996-02-29
CA2198120A1 (en) 1996-02-29
FI970716L (fi) 1997-02-20
NO970787L (no) 1997-02-20
FI970716A0 (fi) 1997-02-20
KR970705388A (ko) 1997-10-09
ATE200623T1 (de) 2001-05-15
ZA956988B (en) 1997-02-21
GR3036225T3 (en) 2001-10-31
AU3409895A (en) 1996-03-14
DE69520741T2 (de) 2001-10-11
HUT76854A (en) 1997-12-29
JPH10504579A (ja) 1998-05-06
PT771201E (pt) 2001-07-31
EP0771201B1 (de) 2001-04-18
AU706953B2 (en) 1999-07-01
NO970787D0 (no) 1997-02-20
DE69520741D1 (de) 2001-05-23
MY131931A (en) 2007-09-28
FI970716A7 (fi) 1997-02-20
IL115018A0 (en) 1995-12-08
DK0771201T3 (da) 2001-05-07
ES2155895T3 (es) 2001-06-01

Similar Documents

Publication Publication Date Title
DE69427800T2 (de) Methode zur Hemmung der Endometriose
JPH07304661A (ja) １，１，２−トリフェニルブタ−１−エン誘導体類を使用する子宮内膜炎及び子宮類線維腫疾患の抑制法
JPH07196500A (ja) 閉経期後症候群に関連する血管運動症状および併発性心理的障害を抑制するための医薬組成物
CZ287247B6 (en) Medicament for inhibition of uterus fibrosis
JPH07215858A (ja) 機能障害性子宮出血を抑制する方法
AU701701B2 (en) Methods of inhibiting breast disorders
CZ322594A3 (en) Pharmaceutical preparation for inhibiting problems of central neural system of a postmenopausal woman
JPH08231394A (ja) 骨損失抑制用製剤
CZ322194A3 (en) Pharmaceutical preparation for inhibiting turner syndrome
EP0662325A2 (de) Hemmung einer Fehlentwicklung der Ovarien, verspüteter Pubertät oder sexuellem Infantilismus
CZ52297A3 (en) Pharmaceutical preparation for inhibiting primary endometrial hyperplasia
AU688112B2 (en) Methods of inhibiting endometrial cancer
US5502074A (en) Benzothiophenes for bone healing and fracture repair
CZ83997A3 (en) Inhibition methods of endometrial mitoses
HUT77381A (hu) Eljárás növekedési hormonok hatásainak inhibiálására alkalmas benzotiofén-származékokat tartalmazó gyógyszerkészítmények előállítására
JPH08245381A (ja) 子宮内膜炎抑制用製剤
JPH08231395A (ja) 子宮類線維腫疾患抑制用製剤
CN1169678A (zh) 防治原发性子宫内膜增生的方法